TUESDAY, June 25, 2024 -- A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects...

Prolonged-release ketamine tablet has potential as affordable and convenient treatment for severe depression and with minimal side effects

A novel tablet formulation of ketamine has demonstrated potential in the treatment of severe depression, providing a possible substitute for the...

AUCKLAND, New Zealand, June 24, 2024. Douglas Pharmaceuticals, New Zealand's largest pharmaceutical company, is pleased to announce that results from...

More than 85% of women – and more than 300 million people worldwide at any given time – use hormonal contraceptives for at least five years of...

An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...

Patients with treatment-refractory cancers who received eligibility and testing waivers to participate in a large basket/umbrella oncology trial had...

WA’s first trial of psilocybin - from magic mushrooms - to help treatment-resistant depression is underway, with the first patient reporting good...

The 16-week Plants for Joints trial investigated the effects of a multidisciplinary lifestyle intervention in people with RA, as compared to usual...